Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Patent Number 10213401

US 10213401 B2
Application Number16034123
Publication NumberUS 20180338940 A1
Pendency7 months, 19 days
Filled DateJul 12, 2018
Priority DateJul 13, 2017
Publication DateNov 29, 2018
Expiration DateJul 12, 2037
Inventor/ApplicantsMartin E. Sanders
Roshantha A. Chandraratna
ExaminesHUFF, SHEELA JITENDRA
Art Unit1643
Technology Center1600
Assignments
Io Therapeutics Inc.
Current
Io Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.